Keywords: Farmakokinetics جمعیت; clinical pharmacokinetics; pediatric; pharmacokinetic/pharmacodynamic models; population pharmacokinetics; cancer chemotherapy;
مقالات ISI Farmakokinetics جمعیت (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Farmakokinetics جمعیت; Cerebrospinal fluid; craniotomy; intracranial infection; norvancomycin; population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; pharmacokinetic/pharmacodynamic models; pharmacokinetics/pharmacodynamics; pharmacokinetics; metabolism; metabolite kinetics; clinical pharmacokinetics; population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; augmented renal function; meropenem; MIC; population pharmacokinetics; prolonged infusion; target attainment;
Keywords: Farmakokinetics جمعیت; ECOFF; EUCAST epidemiological cut-off value; EUCAST; European committee on antimicrobial susceptibility testing; MIC; minimal inhibitory concentration; MCS; Monte Carlo simulations; PTA; probability of target attainment; Vancomycin (CID: 14969); Amoxicill
Keywords: Farmakokinetics جمعیت; alfaxalone; cats; pharmacology; population pharmacokinetics; target-controlled infusion;
Keywords: Farmakokinetics جمعیت; gentamicin; predictive performance; population pharmacokinetics; critical illness; hypoalbuminemia;
Keywords: Farmakokinetics جمعیت; Cystic fibrosis; Population pharmacokinetics; Metabolite formation; Renal clearance; Nonrenal clearance; Allometric scaling; Parametric and nonparametric bootstrap;
Keywords: Farmakokinetics جمعیت; Valsartan; Population pharmacokinetics; Drug-drug interaction; Fixed-dose combination; NONMEM;
Keywords: Farmakokinetics جمعیت; Psychosocial stress; Cortisol; Population pharmacokinetics; Differential equation model; Non-compartmental analyses; Statistical power;
Keywords: Farmakokinetics جمعیت; Furosemide; Hypertension; Population pharmacokinetics; Phoenix NLME;
Keywords: Farmakokinetics جمعیت; Population pharmacokinetics; NONMEM; Atazanavir; Dose optimisation; Thai patients; HIV-infected patients;
Keywords: Farmakokinetics جمعیت; Linezolid; TDM; Tuberculosis; Multi-drug resistance; Population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; Gentamicin; Population pharmacokinetics; Critical illness; Renal function; Hypoalbuminaemia;
Keywords: Farmakokinetics جمعیت; Neonates; Population pharmacokinetics; Phenobarbital; Dose;
Keywords: Farmakokinetics جمعیت; population pharmacokinetics; covariate models; automatic modeling; gene expression programming; genetic algorithm; ELS; extended nonlinear least squares; GA; genetic algorithm; GEP; gene expression programming; IVIVC; in vitro-in vivo correlation;
Keywords: Farmakokinetics جمعیت; pulmonary delivery/absorption; population pharmacokinetics; aerosol; pediatric; clinical pharmacokinetics;
Keywords: Farmakokinetics جمعیت; Population pharmacokinetics; Hydrocortisone; Secondary adrenal insufficiency;
Keywords: Farmakokinetics جمعیت; Area under the concentration curve; Continuation ratio model; D-optimum sampling times; One-compartment pharmacokinetic model; Population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; Biapenem; Population pharmacokinetics; Monte Carlo simulation; %T>MIC; Lower respiratory tract infections
Keywords: Farmakokinetics جمعیت; population pharmacokinetics; anesthesia; urethane; voriconazole; fluconazole; antifungal agents; elimination; renal excretion; metabolism;
Keywords: Farmakokinetics جمعیت; Teicoplanin; Protein binding; Free; Hypoalbuminaemia; Population pharmacokinetics; TDM;
Keywords: Farmakokinetics جمعیت; Tuberculosis; Rifampin; Population pharmacokinetics; Antituberculosis agents; NONMEM;
Keywords: Farmakokinetics جمعیت; Cefuroxime; Metronidazole; Population pharmacokinetics; Colorectal surgery; PK/PD analysis; Prophylaxis; NONMEM;
Keywords: Farmakokinetics جمعیت; meta-analysis; nonlinear mixed-effect modeling; pharmacokinetics; population pharmacokinetics; veterinary medicine; drug depletion; drug withdrawal time; clearance; distribution; formulation;
Keywords: Farmakokinetics جمعیت; degradation product; pharmacokinetics; physiological model; population pharmacokinetics; Monte Carlo; stability
Keywords: Farmakokinetics جمعیت; Linezolid; Population pharmacokinetics; Thrombocytopenia; Therapeutic drug monitoring
Keywords: Farmakokinetics جمعیت; Kidney transplantation; Plasma proteins; Population pharmacokinetics; Tacrolimus; Therapeutic monitoring
Keywords: Farmakokinetics جمعیت; Amlodipine; Sparse sampling; Model estimation; Population pharmacokinetics
Keywords: Farmakokinetics جمعیت; collagen binding; osteoporosis; peptides; peptide delivery; pharmacokinetic/pharmacodynamic models; population pharmacokinetics; preclinical pharmacokinetics; PTH(1-34); teriparatide; AIC, akaike information criterion; CBD, collagen-binding domain; PTH,
Keywords: Farmakokinetics جمعیت; Ethnicity; Genetics; Hmong; Methadone; Pharmacogenetics; Population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; AIC; Akaike information criteria; BCS; Biopharmaceutics Classification System; BLQ; below the limit of quantification; CI; confidence interval; CYP2D6; cytochrome P450 2D6; GC-MS; gas chromatography coupled to mass spectrometry; IIV; interindividual var
Keywords: Farmakokinetics جمعیت; digoxin; nonlinear mixed-effects modeling; NONMEM; nutritional status; population pharmacokinetics;
Keywords: Farmakokinetics جمعیت; AUCÏ; Area under the curve within the dosing interval; BS; Bootstrap; CL; Clearance; CLCR; Creatinine clearance; CP; Cerebral palsy; GAGE; Gestational age; GERD; Gastroesophageal reflux disease; IIV; Inter-individual variability; MTT; Mean transit time;
Keywords: Farmakokinetics جمعیت; Topiramate; Epilepsy; Population pharmacokinetics; NONMEM
An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)
Keywords: Farmakokinetics جمعیت; Rivaroxaban; Atrial fibrillation; Anticoagulation; Prothrombin time; Serum concentration; Population pharmacokinetics;
Population pharmacokinetics of oxaliplatin after intraperitoneal administration with hyperthermia in Wistar rats
Keywords: Farmakokinetics جمعیت; Population pharmacokinetics; Oxaliplatin; Intraperitoneal chemotherapy; Peritoneal metastasis; Animal models;
Prophylactic cefazolin concentrations in morbidly obese patients undergoing sleeve gastrectomy: do we achieve targets?
Keywords: Farmakokinetics جمعیت; Population pharmacokinetics; Surgical prophylaxis; Bariatric surgery; Cefazolin;
Population pharmacokinetics of nintedanib in patients with idiopathic pulmonary fibrosis
Keywords: Farmakokinetics جمعیت; Covariates; Idiopathic pulmonary fibrosis; Nintedanib; Population pharmacokinetics;
Population Pharmacokinetics and Dosing Simulations of Ceftazidime in Chinese Neonates
Keywords: Farmakokinetics جمعیت; ceftazidime; population pharmacokinetics; neonates; postmenstrual age; modeling and simulation;
Population pharmacokinetics of valproic acid in epileptic children: Effects of clinical and genetic factors
Keywords: Farmakokinetics جمعیت; Valproic acid; Population pharmacokinetics; LEPR; Pharmacogenetics; Epileptic children;
Optimization of maintenance therapy of Risperidone with CYP2D6 genetic polymorphisms through an extended translational framework-based prediction of target occupancies/clinical outcomes
Keywords: Farmakokinetics جمعیت; RO; receptor occupancy; EPS; extrapyramidal symptoms; PK; pharmacokinetic; PD; pharmacodynamic; EM; extensive metabolizer; IM; intermediate metabolizer; PM; poor metabolizer; PBPKPD; physiology-based pharmacokinetic and pharmacodynamic; P-gp; P-glycoprote
Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens
Keywords: Farmakokinetics جمعیت; Cefepime; β-Lactams; Pharmacology; Population pharmacokinetics; Febrile neutropenia;
Development and validation of a quantification method for cucurbitacins E and I in rat plasma: Application to population pharmacokinetic studies
Keywords: Farmakokinetics جمعیت; Cucurbitacin E; Cucurbitacin I; Rats; LC-MS/MS; Population pharmacokinetics;
Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy
Keywords: Farmakokinetics جمعیت; Levetiracetam; Population pharmacokinetics; Non-linear mixed effect model; Seizure control; Dose titration;
Original ResearchA Bayesian Approach for Population Pharmacokinetic Modeling of Alcohol in Japanese Individuals
Keywords: Farmakokinetics جمعیت; Population pharmacokinetics; pharmacogenomics; aldehyde dehydrogenase 2; MCMC Bayesian estimation; NONMEM;
Short communicationPopulation pharmacokinetic modelling of valproic acid and its selected metabolites in acute VPA poisoning
Keywords: Farmakokinetics جمعیت; Valproic acid; Population pharmacokinetics; Acute poisoning; Metabolic pathway; Monolix;
Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis
Keywords: Farmakokinetics جمعیت; Second-line anti-tuberculosis drugs; Multi-drug-resistant tuberculosis; Population pharmacokinetics;
Endogenous metabolites that are substrates of organic anion transporter's (OATs) predict methotrexate clearance
Keywords: Farmakokinetics جمعیت; MTX; methotrexate; HD-MTX; high-dose methotrexate; OH-MTX; hydroxymethotrexate; UCP (I/IÂ +Â III) ratio; urinary coproporphyrin ratio; MRP2; multidrug resistance related protein-2; TDM; therapeutic drug monitoring; POP-PK; population pharmacokinetics; H24
Characterizing the time-course of antihypertensive activity and optimal dose range of fimasartan via mechanism-based population modeling
Keywords: Farmakokinetics جمعیت; Angiotensin II receptor blocker; Hypertension; cardiovascular activity; Enterohepatic recirculation; Population pharmacokinetics; pharmacodynamics; Mechanism-based modeling; Circadian rhythm;